The Expression of Interleukin-17, Interferon-gamma, and Macrophage Inflammatory Protein-3 Alpha mRNA in Patients with Psoriasis Vulgaris

Summary: To investigate the role of Interleukin-17 (IL-17), Interferon-gamma (IFN-γ), and macrophage inflammatory protein-3 alpha (MIP-3α) in the pathogenesis of psoriasis, reverse transcriptase-polymerase chain reaction (RT-PCR) was used to semi-quantitatively analyze the mRNA expression of IL-17, IFN-γ, and MIP-3α in 31 psoriatic lesions and 16 normal skin tissues. The results showed that the mRNA of the three cytokines was present in all specimens. And the expression level of IL-17 mRNA in skin lesions was 1.1416±0.0591, which was significantly higher than that in normal controls (0.8788±0.0344, P<0.001). The expression levels of IFN-γ mRNA were 1.1142±0.0561 and 0.9050±0.0263, respectively, with significant difference(P<0.001). And the expression levels of MIP-3α mRNA in psoriatic lesions was 1.1397±0.0521, which was markedly higher than that in normal controls (0.8681±0.0308, P<0.001). These findings indicate that up-regulated expression of IL-17, IFN-γ, and MIP-3α might be involved in the pathogenesis of psoriasis.

Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma

Background: Insulin?like growth factor?binding protein?3(IGFBP?3) is suggested to predict the radiosensitivity and/or prognosis of patients with esophageal squamous cell carcinoma(ESCC). The present study was designed to investi?gate the clinical and prognostic efects of IGFBP?3 on ESCC.Methods: IGFBP?3 was detected by immunohistochemistry in parain?embedded tissues from 70 ESCC patients treated with radiotherapy alone and further examined by western blotting analysis in 10 pairs of fresh ESCC tissues and adjacent non?malignant esophageal specimens. Receiver operating characteristic(ROC) analysis was used to determine cut?of scores for tumor positivity and to evaluate patient survival status. The χ2 test was performed to analyze the association of IGFBP?3 expression with clinical characteristics and radiotherapy response. Associations between prognostic outcomes and IGFBP?3 expression were investigated using Kaplan–Meier analysis and the Cox proportional hazards model.Results: The threshold for IGFBP?3 positivity was set to greater than 65% [area under the ROC curve(AUC)(45.7%) were deined as having high IGFBP?3 expression= 0.690, P < 0.019]. Of the 70 ESCC patient tissues tested, 32. The levels of IGFBP?3 protein expression were decreased in 70.0%(7 of 10) of ESCC tissues compared with adjacent non?malignant esophageal tissue. In addition, IGFBP?3 expression was associated with pathologic classiication(P < 0.05 for T, N, and M categories and clinical stage). Patients with elevated protein level of IGFBP?3 in the tumor had an improved radiotherapy response and prolonged overall survival(P < 0.001).Conclusions: High level of IGFBP?3 expression in ESCC associates with early clinical stages and are predictive for favorable survival of the patients treated with radiotherapy.

Interplay between micro RNA-17-5p, insulin-like growth factor-Ⅱ through binding protein-3 in hepatocellular carcinoma

AIM: To investigate the effect of microR NA on insulinlike growth factor binding protein-3(IGFBP-3) and hence on insulin-like growth factor-Ⅱ(IGF-Ⅱ) bioavailability in hepatocellular carcinoma(HCC).METHODS: Bioinformatic analysis was performed using microrna.org, DIANA lab and Segal lab softwares. Total RNA was extracted from 23 HCC and 10 healthy liver tissues using mir Vana mi RNA Isolation Kit. microR NA-17-5p(miR-17-5p) expression was mimicked and antagonized in Hu H-7 cell lines using Hi Per Fect Transfection Reagent, then total RNA was extracted using Biozol reagent then reverse transcribed into cD NA followed by quantification of mi R-17-5p and IGFBP-3 expression using Taq Man real-time quantitative PCR. Luciferase reporter assay was performed to validate the binding of miR-17-5p to the 3'UTR of IGFBP-3. Free IGF-Ⅱ protein was measured in transfected Hu H-7 cells using IGF-Ⅱ ELISA kit. RESULTS: Bioinformatic analysis revealed IGFBP-3 as a potential target for miR-17-5p. Screening of miR-17-5p and IGFBP-3 revealed a moderate negative correlation in HCC patients, where mi R-17-5p was extensively underexpressed in HCC tissues(P = 0.0012), while IGFBP-3 showed significant upregulation in the same set of patients(P = 0.0041) compared to healthy donors. Forcing mi R-17-5p expression in Hu H-7 cell lines showed a significant downregulation of IGFBP-3 mR NA expression(P = 0.0267) and a significant increase in free IGF-Ⅱ protein(P = 0.0339) compared to mock untransfected cells using unpaired t-test. Luciferase assay validated IGFBP-3 as a direct target of mi R-17-5p; luciferase activity was inhibited by 27.5% in cells co-transfected with miR-17-5p mimics and the construct harboring the wild-type binding region 2 of IGFBP-3 compared to cells transfected with this construct alone(P = 0.0474).CONCLUSION: These data suggest that regulating IGF-Ⅱ bioavailability and hence HCC progression can be achieved through targeting IGFBP-3 via manipulating the expression of miR NAs.

Tribulus terrestris extracts alleviate muscle damage and promote anaerobic performance of trained male boxers and its mechanisms： Roles of androgen, IGF-1, and IGF binding protein-3

Purpose: To investigate the effects of Tribulus terrestris(TT) extracts on muscle mass, muscle damage, and anaerobic performances of trained male boxers and its mechanisms: roles of plasma androgen, insulin growth factor 1(IGF-1), and IGF-1 binding protein-3(IGFBP-3).Methods: Fifteen male boxers were divided into exercise group(E, n = 7) and exercise plus TT group(E + TT, n = 8). The 2 groups both undertook3-week high-intensity and 3-week high-volume trainings separated by a 4-week rest. TT extracts(1250 mg/day) were orally administered by boxers in E + TT group. TT extract compositions were detected by UHPLC–Q-TOF/MS. Before and at the end of the 2 trainings, muscle mass, anaerobic performance, and blood indicators were explored.Results: Compared with E group, decreases of plasma CK(1591.5 ± 909.6 U/L vs. 2719.9 ± 832.5 U/L) and IGFBP-3(3075.5 ± 1072.5 ng/m L vs. 3950.8 ± 479.3 ng/m L) as well as increases of mean power(MP, 459.4 ± 122.3 W vs. 434.6 ± 69.5 W) and MP/body weight(MP/BW, 7.5 ± 0.9 W/kg vs. 7.1 ± 1.1 W/kg) were detected in E + TT group after a high-intensity training. For high-volume training, reduction of IGFBP-3(2946.4 ± 974.1 ng/m L vs. 3632.7 ± 470.1 ng/m L) and increases of MP(508.7 ± 103.2 W vs. 477.8 ± 49.9 W) and MP/BW(8.2 ± 0.3 W/kg vs.7.5 ± 0.9 W/kg) were detected in E + TT group, compared with E group. Muscle mass, blood levels of testosterone, dihydrotestosterone(DHT),and IGF-1 were not signifiantly changed between the 2 groups.Conclusion: Taking 1250 mg capsules containing TT extracts did not change muscle mass and plasma levels of testosterone, DHT, and IGF-1 but significantly alleviated muscle damage and promoted anaerobic performance of trained male boxers, which may be related to the decrease of plasma IGFBP-3 rather than androgen in plasma.

Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men

Aim： To investigate the relationships of serum testosterone, insulin-like growth factor （IGF）- 1 and IGF-binding protein （IGFBP）-3 levels with prostate cancer risk and also with known prognostic parameters of prostate cancer in Korean men who received radical retropubic prostatectomy （RRP） for clinically-localized prostate cancer. Methods： Serum levels of total testosterone, free testosterone, IGF-1 and IGFBP-3 were determined in 592 patients who subsequently received prostate biopsy. Results were compared between patients who eventually received RRP for prostate cancer （n = 159） and those who were not diagnosed with prostate cancer from biopsy （control group, n = 433）. Among the prostate cancer only patients, serum hormonal levels obtained were analyzed in relation to serum prostate specific antigen （PSA）, pathological T stage and pathological Gleason score. Results： Prostate cancer patients and the control group demon- strated no significant differences regarding serum levels of total testosterone, free testosterone, IGF-I and IGFBP-3 across the different age groups. Among the cancer only patients, no significant associations were observed for serum levels of total testosterone, free testosterone, IGF-1 and IGFBP-3 levels with pathological T stage, pathological Oleason score and preoperative PSA. Conclusion： Our data indicate that simple quantifications of serum testosterone and IGF-1 along with IGFBP-3 levels might not provide useful clinical information in the diagnosis of clinically localized prostate cancer in Korean men. Also, our results suggest that serum levels of testosterone, IGF-1 and IGFBP-3 might not be significantly associated with known prognostic factors of clinically localized prostate cancer in Korean men. （Asian J Androl 2008 Mar; 10： 207-213）

Increased expression of insulin-like growth factor-binding protein-3 is implicated in erectile dysfunction in two-kidney one-clip hypertensive rats after propranolol treatment

This study aimed to investigate the role of insulin-like growth factor-binding protein-3 （IGFBP-3） in erectUe dysfunction （ED） in two-kidney one-clip （2K-1C） hypertensive rats treated with the β-blocking agent propranolol. Adult male Wistar rats were randomly divided into three groups： a normal control group, a hypertensive control group and a propranolol treatment group （n=9）. After 4 weeks of propranolol treatment, intracavemous pressure （ICP） responses to electrical stimulation of the cavernous nerves were evaluated. The expression of IGFBP-3 and insulin-like growth factor-1 （IGF-1） mRNA and protein in the rat cavernous tissue were detected by quantitative real-time PCR and Western blot, respectively. The concentration of cyclic guanosine monophosphate （cGMP） in the cavernous tissue was determined by enzyme-linked immunosorbent assay （ELISA）. Cavernosal pressure in response to cavernous nerve stimulation was decreased 4 weeks after propranolol treatment （P〈0.01, compared to the hypertensive control group）. IGFBP-3 mRNA and protein expression was increased in the propranolol treatment group compared to the hypertensive control group （P〈O.01）, whereas IGF-1 expression was decreased in the propranolol treatment group compared to the hypertensive control group （P〈0.01）. In addition, cavernous cGMP concentration was decreased in the prepranolol treatment group compared to the hypertensive control group （P〈0.01）. Taken together, these results suggest that the upregulation of IGFBP-3 may play a role in the development of ED in hypertensive rats.

Improved Osteointegration of Ti-6Al-4V-implants of Different Surface Texture by the Use of Bone Morphogenetic Protein-3 (BMP-3)

Half of altogether 60 cylindrical implant devices made of titanium-aluminum-vanadium alloy （ Ti-6Al-4V） were plusna-sprayed with a hydroxyapatite-couting and the other half had a corundum blasted porous surface. 15 implants of each group of the titanium test buplants were coated with 230 μg porcine, high-purified BMP- 3-precipitute per implant. In each case a BMP- 3-couted and an uncoated control-device were implanted into the femoral part of the putellofemoral joint of the right and left leg of 30 adult giant rabbits. Histomorphological and histomorphometrical we found in both groups with BMP- 3-coated test devices an improved osteointegrution. Stutistical evaluation using the t-test for matched samples showed 5 weeks after surgery a significant higher volume of tony formed bone of the BMP- 3-coated corundum- blasted or hydroxyapathe- coated Ti- 6Al- 4 V test devices compared to the non-couted controls of the same t）pe （p 〈 0.01, t-test for matched samples）. In both implant groups with BMP-couting a synergetic effect was verifiable although the bone ongrowth in the hydroxyaputite coated implants was more extensive than in the corundum blasted implants. Light microscopy demonstrated osteointegrution without connective tissue membrane around the surface of the implants. Our results indicate that composite metal implants,as used in endoprosthetics and implantology , are suitable carriers for BMP- 3 and im proved fixation of the implants can be achieved. The hydroxyapatite surface is superior to the corundum-blasted surface with regards to the observed parameters because of its pronounced bioactivity and its osteoconductive characteristics.

Insulin-like growth factor-binding protein-3 inhibits IGF-1-induced proliferation of human hepatocellular carcinoma cells

OBJECTIVE Basic fibroblast growth factor(b FGF)and platelet-derived growth factor(PDGF)produced by hepatocellular carcinoma(HCC)cells are responsible for the cell growth.Accumulating evidence shows that insulin-like growth factor-binding protein-3(IGFBP-3)suppresses HCC cell proliferation in both IGF-dependent and independent manners.The present study is to investigate whether treatment with exogenous IGFBP-3 inhibits bF GF and PDGF production and the cell proliferation of HCC cells.METHODS Cell Counting Kit 8 assay were designed to detect HCC cell proliferation,transcription factor early growth response-1(EGR1)involving in IGFBP-3 regulation of b FGF and PDGF were detected by RT-PCR and Western blot assays.Western blot assay was adopted to detect the IGFBP-3 regulating insulin-like growth factor 1 receptor(IGF-1R)signaling pathway.RESULTS The present study demonstrates that IGFBP-3 suppressed IGF-1-induced b FGF and PDGF expression while it does not affect their expression in the absence of IGF-1.To delineate the underlying mechanism,Western-blot and RT-PCR assays confirmed that the transcription factor early growth response protein 1(EGR1)is involved in IGFBP-3 regulation of b FGF and PDGF.IGFBP-3 inhibition of type 1 insulin-like growth factor receptor(IGF1R),ERK and AKT activation is IGF-1-dependent.Furthermore,transient transfection with constitutively activated AKT or MEK partially blocks the IGFBP-3 inhibition of EGR1,b FGF and PDGF expression.CONCLUSION In conclusion,these findings suggest that IGFBP-3suppresses transcription of EGR1 and its target genes b FGF and PDGF through inhibiting IGF-1-dependent ERK and AKT activation.It demonstrates the importance of IGFBP-3 in the regulation of HCC cell proliferation,suggesting that IGFBP-3 could be a target for the treatment of HCC.

Changes of insulin-like growth factor-Ⅱ and insulin-like growth factor binding protein-3 in cerebrospinal fluid of children with tuberculous meningitis

BACKGROUND： Recent studies have found that insulin-like growth factors （IGFs） and insulin-like growth factor binding protein-3 （IGFBP-3） have stronger neurotrophic and neuroprotective effects. But whether their levels in cerebrospinal fluid could be used as an auxiliary indicator in differentially diagnosing tuberculous meningitis and viral encephalitis is not yet clear. OBJECTIVE： To explore the changes of insulin-like growth factor-Ⅱ （IGF-Ⅱ ） and IGFBP-3 in cerebrospinal fluid （CSF） of children with tuberculous meningitis and the significance of the changes. DESIGN： A non-randomized concurrent controlled study. SETTING： Department of Pediatric Internal Medicine, the First Affiliated Hospital of Xinxiang Medical College. PARTICIPANTS： Thirty children with tuberculous meningitis （14 males and 16 females） were selected from the Department of Pediatric Internal Medicine, the First Affiliated Hospital of Xinxiang Medical College from January 2005 to December 2006. Tuberculous meningitis was diagnosed according to their clinical manifestations, the history of close contact with tuberculosis, typical cerebrospinal fluid changes of tuberculous meningitis, positive tuberculosis antibody and effective antituberculosis treatment. There were 30 children （13 males and 17 females） with viral encephalitis, and viral encephalitis was diagnosed according to epidemiological history, clinical manifestations, conventional and biochemical changes of cerebrospinal fluid, and negative bacteriology judgment. Meanwhile, 30 children （13 males and 17 females） without infectious and central nervous system disease were selected as the control group. Informed consent was obtained from the parents of all the enrolled children. METHODS： ①The lumbar puncture operation was implemented immediately to obtain cerebrospinal fluid （3 mL）. The contents of IGF-Ⅱ and IGFBP-3 were detected with immunoradiometric assay. The concentrations of glucose and protein in cerebrospinal fluid were determined with a dry-chemical method. The number of white blood cells was counted by Fushi Method. ②The Pearson correlation analysis was used to analyze the correlation of the contents of IGF-Ⅱ and IGFBP-3 in cerebrospinal fluid with the leucocyte counting and the concentrations of glucose and protein in cerebrospinal fluid. MAIN OUTCOME MEASURES： The contents of IGF- Ⅱ and IGFBP-3 in cerebrospinal fluid, and their correlation with the leucocyte counting and the concentrations of glucose and protein in cerebrospinal fluid. RESULTS： ①Contents of IGF-Ⅱ and IGFBP-3 in cerebrospinal fluid： The contents of IGF-Ⅱ and IGFBP-3 in cerebrospinal fluid in the tuberculous meningitis group were significantly higher than those in the encephalitis virus group and control group （P 〈 0.05）. There was no significant difference in the contents of IGF- Ⅱ and IGFBP-3 in cerebrospinal fluid between the viral encephalitis group and control group （P 〉 0.05）. ②Correlation： The IGF- Ⅱ and IGFBP-3 contents in cerebrospinal fluid were positively correlated with the protein concentration in cerebrospinal fluid （r =0.821, 0.855, P 〈 0.01）, but negatively with the glucose （r =0.742, - 0.605, P 〈 0.01）. CONCLUSION- ①IGFs and IGVBPs are involved in the pathophysiological process of tuberculous meningitis, as well as the glucose and protein metabolism in cerebrospinal fluid. ②The IGF-Ⅱ and IGFBP-3 contents in cerebrospinal fluid can be used as the auxiliary indicators to differentially diagnose tuberculous meningitis and viral enceohalitis.

外周血受体相互作用蛋白激酶3、混合系列蛋白激酶样结构域水平与新生儿坏死性小肠结肠炎病情严重程度的关系

目的分析新生儿坏死性小肠结肠炎(NEC)患儿外周血受体相互作用蛋白激酶3(RIPK3)、混合系列蛋白激酶样结构域(MLKL)的表达情况及其与病情严重程度的关系。方法选取92例NEC患儿纳入NEC组,并根据病情严重程度进一步分为轻度NEC组(Ⅰ级)60例和重度NEC组(Ⅱ~Ⅲ级)32例,另选取同期诊治的60例腹股沟斜疝患儿纳入对照组。采用实时荧光定量聚合酶链反应检测外周血RIPK3 mRNA、MLKL mRNA表达;采用Pearson相关分析法明确NEC组外周血RIPK3 mRNA与MLKL mRNA表达的相关性;采用免疫印迹法检测NEC回肠组织和正常回肠组织中RIPK3、MLKL蛋白表达;采用多因素Logistic回归分析明确重度NEC发生的独立危险因素。绘制受试者工作特征曲线,分析外周血RIPK3 mRNA、MLKL mRNA单独及联合预测重度NEC的价值。结果NEC组外周血RIPK3 mRNA、MLKL mRNA相对表达量分别为(2.41±0.52)、(3.03±0.64),高于对照组的(1.02±0.21)、(0.93±0.20),差异有统计学意义(P<0.001)。NEC回肠组织中RIPK3、MLKL蛋白相对灰度值分别为(1.20±0.21)、(1.13±0.24),高于正常回肠组织的(0.34±0.12)、(0.32±0.11),差异有统计学意义(P<0.05)。NEC组患儿外周血RIPK3 mRNA与MLKL mRNA相对表达量呈正相关(r=0.623,P<0.001)。重度NEC组合并气腹征、多器官功能障碍综合征、败血症者占比和RIPK3 mRNA、MLKL mRNA相对表达量均高于轻度NEC组,差异有统计学意义(P<0.05);RIPK3 mRNA、MLKL mRNA相对表达量升高是重度NEC发生的独立危险因素(P<0.05)。外周血RIPK3 mRNA、MLKL mRNA联合预测重度NEC的曲线下面积大于RIPK3 mRNA、MLKL mRNA单独预测(Z=4.127、4.261,P<0.05)。结论RIPK3 mRNA、MLKL mRNA在NEC患儿外周血中表达升高,两者均与NEC病情严重程度有关,且两者联合检测对重度NEC具有较高的预测价值。

入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ水平与CHB肝纤维化严重程度的相关性及对疾病预后的预测价值

目的探讨入院时血清转化生长因子-β1(TGF-β1)、Smad同源蛋白2(Smad2)、Smad同源蛋白3(Smad3)及透明质酸(HA)、Ⅲ型前胶原(PCⅢ)、层黏连蛋白(LN)、Ⅳ型胶原(CⅣ)水平与慢性乙型肝炎(CHB)肝纤维化严重程度的相关性及联合检测对疾病预后的预测价值。方法选取河南省中医院2021年3月至2022年3月收治的78例CHB肝纤维化患者作为研究组,选择同期78名健康体检者作为对照组。比较研究组和对照组及不同肝纤维化分期、不同炎症活动分级CHB肝纤维化患者入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平;分析入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平与肝纤维化分期、炎症活动分级的相关性。CHB肝纤维化患者治疗3个月后,根据患者预后分为预后良好和预后不良亚组,比较预后良好和预后不良患者入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平;分析入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平联合检测对CHB肝纤维化患者预后不良的预测价值。结果研究组入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ高于对照组(P<0.05);不同肝纤维化分期、炎症活动分级CHB肝纤维化患者入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ比较:S1<S2<S3<S4、G1<G2<G3<G4,差异有统计学意义(P<0.05);入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ水平与肝纤维化分期、炎症活动分级均呈正相关(P<0.05)。预后良好患者入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ水平均低于预后不良患者(P<0.05);入院时血清TGF-β1、Smad2、Smad3、HA、LN、PCⅢ、CⅣ水平联合预测肝纤维化患者预后不良的曲线下面积(AUC)优于各指标单一检测(P<0.05)。结论CHB肝纤维化患者入院时血清TGF-β1、Smad2、Smad3、HA、PCⅢ、LN、CⅣ水平均呈现高表达,且与肝纤维化分期、炎症活动分级密切相关,其联合检测对CHB肝纤维化患者预后有较高的预测价值,可用于评估CHB肝纤维化患者病情严重程度和预后,为制定针对性治疗措施提供参考。

颅脑损伤术后颅脑感染血清NLRP3、SAA及NFκB的临床意义

目的探讨血清寡聚化结构域样受体蛋白3(NLRP3)、淀粉样蛋白A(SAA)及核转录因子(NFκB)在颅脑损伤术后颅脑感染中的诊断价值。方法选择2020年6月至2022年6月江苏省如皋市人民医院接诊的70例颅脑损伤患者为研究对象,根据感染情况将感染者设为感染组(n=19),未感染者设为对照组(n=51),分析血清NLRP3、SAA及NFκB在颅脑损伤术后颅脑感染中的诊断价值。结果感染组患者血清NLRP3、SAA及NFκB水平显著高于对照组,差异有统计学意义(P<0.05);NLRP3、SAA及NFκB水平:轻度感染<中度感染<重度感染,差异有统计学意义(P<0.05);预后不良组患者血清NLRP3、SAA及NFκB水平显著高于预后良好组,差异有统计学意义(P<0.05);ROC结果显示,血清NLRP3预测颅脑损伤术后颅脑感染的AUC为0.634,灵敏度为63.43%,特异度为67.40%,截断值为114.02 pg/mL;血清SAA预测颅脑损伤术后颅脑感染的AUC为0.715,灵敏度73.50%,特异度为69.00%,截断值为30.99 mg/L;血清NFκB预测颅脑损伤术后颅脑感染的AUC为0.914,灵敏度为81.40%,特异度为70.00%,截断值为38.27μg/mL,联合检测较单独检测特异度、准确度更高(P<0.05)。结论血清NLRP3、SAA及NFκB在颅脑损伤术后颅脑感染患者中均异常高表达,且三指标联合检测颅脑损伤术后颅脑感染诊断效能更高,临床应用价值高。

茵陈水提物对多药耐药蛋白3基因突变致新生儿肠外营养相关性胆汁淤积的保护作用

目的探讨茵陈水提物对多药耐药蛋白3(MDR3)基因突变导致的新生儿肠外营养相关性胆汁淤积(PNAC)的保护作用及可能机制。方法①将人原代培养肝细胞应用体外细胞培养、CRISPR/Cas9慢病毒感染、MDR3突变基因导入等技术处理后,比较1%脂肪乳诱导处理前(0)和处理后16、32、48 h不同时间点肝细胞上清液中肝胆生化指标〔丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、总胆红素(TBil)、直接胆红素(DBil)、间接胆红素(IBil)、总胆汁酸(TBA)〕的水平,确定构建MDR3基因突变PNAC肝细胞模型脂肪酸诱导所需的时间。②将人原代培养肝细胞株按随机数字表法分为空白对照组、MDR3基因野生型组、MDR3基因突变组、茵陈水提物干预组。空白对照组只用培养液处理,MDR3基因野生型组应用慢病毒感染融入野生型MDR3基因和培养液培养,MDR3基因突变组应用慢病毒感染慢病毒导入MDR3(c.485T>A、c.2793insA、c.1031G>A、c.3347G>A)突变基因和培养液培养,茵陈水提物干预组应用慢病毒感染导入MDR3突变基因和培养液培养的基础上,加入100 g/L茵陈水提物预处理,然后将4组肝细胞分别加入1%脂肪乳诱导处理,处理时间为构建MDR3基因突变PNAC肝细胞模型脂肪酸诱导所需时间。采用酶联免疫吸附试验(ELISA)测定4组肝细胞上清液中肝胆生化(ALT、AST、TBil、DBil、IBil、TBA)水平,采用实时荧光定量聚合酶链反应(RT-PCR)检测4组肝细胞编码MDR3、胆盐输出泵(BSEP)、多药耐药相关蛋白(MRP)2~4和肿瘤坏死因子-α(TNF-α)的三磷酸腺苷结合盒蛋白(ABCB4、ABCB11、ABCC2、ABCC3、ABCC4)和TNF基因mRNA的表达丰度。结果与空白对照组和MDR3基因野生型组比较,MDR3基因突变组在经1%脂肪乳诱导处理前和处理后16 h肝细胞上清液中肝胆生化指标(ALT、AST、TBil、DBil、IBil、TBA)水平比较差异无统计学意义,经1%脂肪乳诱导处理32 h和48 h MDR3基因突变组肝细胞上清液肝胆生化指标(ALT、AST、TBil、DBil、IBil、TBA)水平均明显升高(均P<0.05),确定构建MDR3基因突变PNAC肝细胞模型脂肪酸诱导所需的时间为32 h。与MDR3基因突变组比较,茵陈水提物干预组肝细胞在脂肪乳处理后32 h肝细胞上清液中肝胆生化指标(ALT、AST、TBil、DBil、TBA)水平均明显降低〔ALT(ng/L):148.3±2.3比164.9±7.0,AST(ng/L):2767.4±78.8比3239.4±107.1,TBi(lμmol/L):7.6±0.2比13.6±0.3,DBi(lμmol/L):1.8±0.1比5.7±0.2,TBA(μmol/L):3.4±0.2比6.7±0.1,均P<0.05〕;空白对照组、MDR3基因野生型组、MDR3基因突变组和茵陈水提物干预组肝细胞编码MDR3、MRP2、MRP3、MRP4的ABCB4、ABCC2、ABCC3、ABCC4基因mRNA表达丰度差异无统计学意义;TNF基因mRNA在MDR3基因突变组呈高表达(2-ΔΔCt:1.258±0.200比1.001±0.052),茵陈水提物干预组呈低表达(2-ΔΔCt:0.387±0.247比1.258±0.200),组间比较差异有统计学意义(P<0.05)。与MDR3基因突变组比较,茵陈水提取物干预组肝细胞编码BSEP的ABCB11基因mRNA的表达丰度明显增高(2-ΔΔCt:2.955±0.479比1.333±0.529,P<0.05)。结论茵陈水提物对MDR3基因突变导致的PNAC有一定保护作用,可能与拮抗炎症反应,降低TNF基因的mRNA表达和改善编码BSEP的ABCB11基因的mRNA表达有关。

PI3K/AKT信号通路对冷却滩羊肉贮藏期间细胞凋亡的影响

以滩羊后腿肉为研究对象,采用10μmol/L磷脂酰肌醇3激酶(phosphoinositide 3-kinase,PI3K)抑制剂LY294002溶液对滩羊肉进行注射处理,4℃条件下分别贮藏0、2、4、6、8 d,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和蛋白质免疫印迹分析PI3K、蛋白激酶B(protein kinase B,AKT)蛋白的表达情况,以此验证PI3K/AKT信号通路抑制的有效性,同时分析滩羊肉贮藏期间能量因子、氧化应激水平、线粒体损伤程度以及胱天蛋白酶(cysteine aspastic acid-specific protease,Caspase)-3活性的变化,以探索PI3K/AKT信号通路对冷却滩羊肉贮藏期间细胞凋亡途径的诱导机制。结果表明,PI3K和AKT蛋白表达量均减少,验证了PI3K/AKT信号通路被抑制的有效性。与对照组相比,LY294002处理组线粒体ATP、糖原含量、琥珀酸脱氢酶和柠檬酸合成酶活性显著下降(P<0.05);线粒体活性氧(reactive oxygen species,ROS)逐渐增多,氧化应激水平和线粒体膜通透性转换孔(mitochondrial permeability transition pore,MPTP)开放程度增加;膜电位显著下降(P<0.05);凋亡因子Caspase-3活性显著升高(P<0.05),表明PI3K/AKT信号通路通过促进ROS产生并与PI3K相互作用,介导了下游Caspase-3的活化,使线粒体结构与功能受损,导致MPTP开放、膜电位降低,进而诱发细胞凋亡。

银苓消肿丸联合碳酸氢钠对痛风性关节炎患者骨破坏因子及NLRP3、NF-κB信号通路的影响

目的探讨银苓消肿丸联合碳酸氢钠在痛风性关节炎治疗中的效果及可能机制。方法选取2022年7月至2023年7月该院收治的98例痛风性关节炎患者为研究对象,按照随机数字表法分为对照组与研究组,每组49例,对照组采用碳酸氢钠治疗,研究组在碳酸氢钠基础上联合银苓消肿丸治疗,比较两组临床疗效、关节疼痛、肿胀及活动障碍评分[关节压痛疼痛视觉模拟评分(VAS)、肿胀、活动障碍];比较两组骨破坏因子[破骨细胞分化因子(RANKL)、抗酒石酸酸性磷酸酶-5b(TRACP-5b)、β-胶联降解产物(β-CTX)]、炎症因子[白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)]、核转录因子-κB(NF-κB)、Nod样受体蛋白3(NLRP3)水平,以及不良反应(消化不良、头晕、血压升高、肌肉疼痛)发生情况。结果研究组、对照组总有效率分别为95.92%、77.55%,研究组明显高于对照组,差异有统计学意义(χ^(2)=7.184,P=0.007)。治疗后,两组VAS、肿胀、活动障碍评分均降低,且研究组低于对照组,差异均有统计学意义(P<0.05)。治疗后,两组RANKL、TRACP-5b、β-CTX水平均降低,且研究组低于对照组,差异均有统计学意义(P<0.05)。治疗后,两组IL-1β、TNF-α、NF-κB、NLRP3水平均降低,且研究组低于对照组,差异均有统计学意义(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论在痛风性关节炎的治疗中应用银苓消肿丸联合碳酸氢钠能够改善关节症状及功能,降低炎症因子水平,有效调节NLRP3、NF-κB信号通路,临床应用价值较高,值得推广。

TNFAIP3和LINC00887在透明细胞肾细胞癌中的表达及临床预后意义

目的检测肿瘤坏死因子α诱导蛋白3(TNFAIP3)和LINC00887在透明细胞肾细胞癌(ccRCC)组织中的表达水平,并研究其表达水平与临床病理参数和预后的关系。方法选取2013年1月至2018年10月该院收治的101例ccRCC患者,检测TNFAIP3和LINC00887分别在ccRCC癌组织和配对的癌旁组织中的表达水平,分析TNFAIP3、LINC00887表达水平与ccRCC患者临床病理参数和预后关系,并分析ccRCC患者预后不良的影响因素。采用Spearman相关系数分析TNFAIP3、LINC00887表达水平的相关性。结果TNFAIP3在ccRCC中的阳性率(37.62%)显著低于癌旁组织(52.48%),差异有统计学意义(χ^(2)=4.500,P=0.034)。LINC00887在ccRCC中表达水平(1.38±0.61)显著高于在癌旁组织中的表达水平(1.03±0.43),差异有统计学意义(t=5.396,P<0.001)。TNFAIP3蛋白阳性率在肿瘤最大径≥4.5 cm、TNM分期Ⅲ~Ⅳ期患者中低于在肿瘤最大径<4.5 cm、TNM分期Ⅰ~Ⅱ期患者,差异有统计学意义(P<0.05)。LINC00887在肿瘤最大径≥4.5 cm、病理分级Ⅲ~Ⅳ级、TNM分期Ⅲ~Ⅳ期患者中表达高于肿瘤最大径<4.5 cm、病理分级Ⅰ~Ⅱ级、TNM分期Ⅰ~Ⅱ期患者,差异有统计学意义(P<0.05)。与TNFAIP3高表达组相比,TNFAIP3低表达组ccRCC患者预后较差,差异有统计学意义(χ^(2)=5.118,P=0.024);与LINC00887低表达组相比,LINC00887高表达组ccRCC患者预后较差,差异有统计学意义(χ^(2)=4.638,P=0.031)。TNFAIP3低表达,LINC00887高表达,病理分级Ⅲ~Ⅳ级和TNM分期Ⅲ~Ⅳ期是ccRCC患者预后不良的危险因素(P<0.05)。Spearman秩相关分析结果,TNFAIP3、LINC00887表达水平在ccRCC中呈负相关(r=-0.638,P=0.012)。结论ccRCC癌组织中TNFAIP3表达水平下调、LINC00887表达水平上调,且呈负相关性,二者可能共同调控ccRCC发生发展,具有成为评估ccRCC患者预后肿瘤标志物的潜力。

基于NLRP3通路探讨线粒体自噬在PCOS卵巢组织炎症反应中的作用

目的基于NOD样受体热蛋白结构域相关蛋白3(NLRP3)通路探讨线粒体自噬在多囊卵巢综合征(PCOS)卵巢组织炎症反应中的作用。方法人卵巢颗粒细胞(GCs)系SVOG用25 nmol/L双氢睾酮(DHT)处理24 h以建立PCOS细胞模型。SVOG细胞用携带NLRP3(Ad-NLRP3)及阴性载体(Ad-EV)或NLRP3 shRNA(sh-NLRP3)及阴性对照(sh-NC)的腺病毒转染,以过表达或敲低NLRP3表达。使用Mito-Tracker染色和GFP-LC3染色评估细胞中线粒体自噬情况。分别通过TUNEL染色、JC-1染色、Mito-SOX染色分析细胞凋亡、线粒体膜电位、线粒体衍生超氧化物产生情况。32只雌性BALB/c小鼠随机分为对照(Con)组、脱氢表雄酮(DHEA)组、DHEA+sh-NC组、DHEA+sh-NLRP3组,每组8只。除Con组外,其他组用DHEA处理小鼠以建立PCOS模型。DHEA+sh-NLRP3组、DHEA+sh-NC组通过尾静脉注射浓度为1×109 TU/ml的慢病毒包装的sh-NLRP3或sh-NC。透射电子显微镜观察各组小鼠卵巢组织中线粒体的超微结构。结果与DHT+sh-NC组相比,DHT+sh-NLRP3组SVOG细胞的NLRP3水平降低(P<0.05)。DHT+sh-NLRP3组SVOG细胞中GFP-LC3和线粒体的共定位较DHT+sh-NC组增加(P<0.05)。与DHT+sh-NC组相比,DHT+sh-NLRP3组SVOG细胞的TUNEL阳性细胞的数目和Mito-SOX荧光密度降低、多聚体JC-1/单体JC-1比值增加(P<0.05)。与Con+Ad-EV组相比,Con+Ad-NLRP3组SVOG细胞的NLRP3水平、TUNEL阳性细胞数目、Mito-SOX荧光密度增加(P<0.05),GFP-LC3和线粒体的共定位以及多聚体JC-1/单体JC-1比值降低(P<0.05)。与Con组相比,DHEA组小鼠卵巢组织中TUNEL阳性细胞、相对活性氧(ROS)强度和受损线粒体百分比均显著增加(P<0.05)。与DHEA+sh-NC组相比,DHEA+sh-NLRP3组卵巢组织中TUNEL阳性细胞、相对ROS强度和受损线粒体百分比均降低(P<0.05)。结论NLRP3激活诱导的线粒体自噬活性导致线粒体功能障碍并促进GCs中线粒体相关凋亡。NLRP3敲低有利于线粒体稳态,并改善GCs对氧化应激损伤的抵抗,从而促进PCOS的恢复。

NLRP3炎症小体在大鼠单侧输尿管梗阻引起肾间质纤维化中的作用及其机制

目的:探讨核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)炎性小体在大鼠单侧输尿管梗阻(UUO)模型肾间质纤维化中的作用,并阐明其可能的作用机制。方法:健康雄性Wistar大鼠30只随机分为假手术组(n=6)和UUO组(n=24),假手术组大鼠仅分离输尿管不结扎,UUO组分别于术后3、7和14 d处死大鼠,并按照处理时间分为UUO 3 d组(n=8)、UUO 7 d组(n=8)和UUO 14 d组(n=8)。HE染色和Masson染色观察各组大鼠肾组织病理形态表现,试剂盒检测各组大鼠肾组织中丙二醛(MDA)水平、超氧化物歧化酶(SOD)活性和羟脯氨酸(HYP)水平,免疫组织化学法检测各组大鼠肾组织中α-平滑肌肌动蛋白(α-SMA)和转化生长因子β1(TGF-β1)蛋白表达水平,Western blotting法检测各组大鼠肾组织中NLRP3蛋白表达水平。结果:HE染色,UUO组大鼠出现明显肾小管扩张,肾间质水肿和增宽,可见较多炎症细胞浸润,部分肾小管腔内可见脱落的上皮细胞。与假手术组比较,UUO 3 d组、UUO 7 d组和UUO 14 d组大鼠HE染色肾间质纤维化评分均明显升高(P<0.05);与UUO 3 d组和UUO 7 d组比较,UUO 14 d组大鼠HE染色肾间质纤维化评分明显升高(P<0.05)。Masson染色,UUO组大鼠肾间质炎症细胞浸润明显,可见明显纤维组织增生;随UUO作用时间增加,大鼠部分肾小管消失,肾间质明显增宽,胶原沉积逐渐增多,皮髓交界处胶原沉积程度更加明显。与假手术组比较,UUO 3 d组、UUO 7 d组和UUO 14 d组大鼠Masson染色肾间质纤维化评分均明显升高(P<0.05);与UUO 3 d组和UUO 7 d组比较,UUO 14 d组大鼠Masson染色肾间质纤维化评分明显升高(P<0.05)。与假手术组比较,UUO 3 d组、UUO 7 d组和UUO 14 d组大鼠梗阻侧肾组织中MDA水平均明显升高(P<0.05),SOD活性明显降低(P<0.05)。与假手术组比较,UUO 3 d组、UUO 7 d组和UUO 14 d组大鼠梗阻侧肾组织中HYP水平均明显升高(P<0.05);与UUO 3 d组比较,UUO 14 d组大鼠梗阻侧肾组织中HYP水平明显升高(P<0.05)。免疫组织化学法,与假手术组比较,UUO 3 d组、UUO 7 d组和UUO 14 d组大鼠肾组织中α-SMA蛋白表达水平明显升高(P<0.05);与UUO 3 d组和UUO 7 d组比较,UUO 14 d组大鼠肾组织中α-SMA蛋白表达水平均明显升高(P<0.05);与假手术组比较,UUO 3 d组、UUO 7 d组和UUO 14 d组大鼠肾小管上皮细胞和肾小管间质组织中TGF-β1蛋白表达水平明显升高(P<0.05);与UUO 3 d组比较,UUO 14 d组大鼠肾小管上皮细胞和肾小管间质组织中TGF-β1蛋白表达水平明显升高(P<0.05)。Western blotting法,与假手术组比较,UUO 7 d组和UUO 14 d组大鼠肾组织中NLRP3蛋白表达水平均明显升高(P<0.05)。结论:NLRP3炎症小体在UUO大鼠肾纤维化过程中发挥重要作用,其作用机制与氧化应激增加和TGF-β1蛋白表达水平升高有关。

2型糖尿病合并甲状腺功能亢进患者血清Sema 5A、IGFBP-3水平与糖代谢指标的相关性分析

目的分析2型糖尿病合并甲状腺功能亢进(以下简称甲亢)患者血清信号素5A(Sema 5A)、胰岛素样生长因子结合蛋白-3(IGFBP-3)水平与糖代谢指标的相关性。方法选取2021年6月至2022年6月邯郸市中心医院收治的73例2型糖尿病合并甲亢患者作为合并组,56例单纯2型糖尿病患者作为糖尿病组,另选取同期在邯郸市中心医院体检的68例健康者作为对照组。比较对照组、糖尿病组、合并组血清Sema 5A、IGFBP-3水平,比较糖尿病组、合并组临床资料[体质量指数、糖尿病病程、空腹血糖(FBG)、餐后2 h血糖(2 h PG)、胰岛素(FIN)、甘油三酯、总胆固醇、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、糖化血红蛋白(HbA1c)、三碘甲腺原氨酸(T_(3))、甲状腺素(T_(4))、游离三碘甲腺原氨酸(FT_(3))、游离甲状腺素(FT_(4))、促甲状腺素(TSH)、促甲状腺激素受体抗体(TRAB)及甲状腺过氧化物酶抗体(TPOAB)、胰岛素抵抗指数(HOMA-IR)]。采用多因素Logisitic回归分析2型糖尿病并发甲亢的危险因素,采用Pearson相关分析2型糖尿病合并甲亢患者血清Sema 5A、IGFBP-3水平与糖代谢指标的相关性,绘制受试者工作特征(ROC)曲线分析血清Sema 5A、IGFBP-3对2型糖尿病合并甲亢的诊断价值。结果合并组血清Sema 5A、IGFBP-3水平高于对照组和糖尿病组,且糖尿病组高于对照组,差异均有统计学意义(P<0.05)。合并组糖尿病病程长于糖尿病组,血清HOMA-IR、FIN、HbA1c、T_(3)、T_(4)、FT_(3)、FT_(4)、TRAB、TPOAB水平高于糖尿病组,TSH水平低于糖尿病组,差异均有统计学意义(P<0.05)。多因素Logisitic回归分析结果显示,HOMA-IR、TPOAB、Sema 5A、IGFBP-3水平升高,TSH水平降低为2型糖尿病并发甲亢的危险因素(P<0.05)。Pearson相关分析结果显示,2型糖尿病并发甲亢患者血清Sema 5A、IGFBP-3水平与HOMA-IR、FBG、2 h PG、FIN、HbA1c、HDL-C水平均呈正相关(P<0.05)。2型糖尿病并发甲亢患者血清Sema 5A、IGFBP-3水平与LDL-C水平呈负相关(P<0.05)。ROC曲线分析结果显示,血清Sema 5A、IGFBP-3诊断2型糖尿病合并甲亢的曲线下面积(AUC)分别为0.854、0.804,2项指标联合诊断的AUC为0.900,且2项指标联合诊断的AUC高于Sema 5A、IGFBP-3单独诊断的AUC(Z联合-Sema 5A=2.156,P=0.043;Z联合-IGFBP-3=2.873,P=0.004)。结论2型糖尿病合并甲亢患者血清Sema 5A、IGFBP-3水平升高,且二者与糖代谢指标密切相关。

外周血TLR4和NLRP3表达与小儿肺炎支原体肺炎病情的相关性分析

目的研究外周血Toll样受体-4(TLR4)、NOD样受体蛋白3(NLRP3)表达与小儿肺炎支原体肺炎(MPP)病情的相关性。方法回顾性选取2023年1月至2023年12月入山西省儿童医院的92例MPP患儿为观察对象,设为观察组;同时选取同期入院体检的40名健康儿童设为对照组。参考病情严重程度将观察组患儿划分为重症组(n=35)与轻症组(n=57)。采集各组儿童的血样,对单个核细胞内NLRP3、TLR4相对表达量予以测定,同时对血清白细胞介素(IL)-18、IL-1β水平予以测定。分析MPP患儿NLRP3、TLR4表达水平与IL-18、IL-1β水平的相关性,以及采用受试者操作特征(ROC)曲线评估MPP病情评估中NLRP3、TLR4价值。结果观察组患儿的NLRP3、TLR4、IL-18、IL-1β水平分别为1.94±0.12、0.76±0.10、(179.78±16.31)pg/mL、(6.82±1.19)pg/mL,均明显高于对照组[1.66±0.10、0.60±0.05、(86.83±13.88)pg/mL、(4.41±1.17)pg/mL],差异均有统计学意义(P<0.05)。重症组患儿的NLRP3、TLR4、IL-18、IL-1β水平分别为2.18±0.19、0.89±0.11、(213.09±19.58)pg/mL、(8.59±1.34)pg/mL,均明显高于轻症组[1.69±0.13、0.68±0.09、(150.57±14.97)pg/mL、(4.97±1.09)pg/mL],差异均有统计学意义(P<0.05)。Pearson分析结果显示,MPP患儿IL-18、IL-1β随NLRP3、TLR4升高而上升,呈正相关(P<0.05)。ROC曲线显示,重症MPP预测中NLRP3、TLR4曲线下面积分别为0.993、0.949,预测价值均较好(P<0.05)。结论MPP患儿的IL-18、IL-1β、NLRP3、TLR4水平均明显上升,且NLRP3、TLR4水平随IL-18、IL-1β水平升高而上升,NLRP3、TLR4可作为MPP患儿病情进展预测的辅助因子。